年间契约型资讯服务
商品编码
1455820
Top300 Bio CDMO:设施索引和生物製造商註册资料库Top 300 Bio CDMO - Facility Index and Biomanufacturers Subscription Database |
该资料库是世界上唯一一个积极追踪400 多家提供生物製药开发和製造服务的公司的 CDMO 设施的合约开发和製造设施资料库。
全球有数百家工厂以临床和商业规模生产生物製剂,到 2023 年,它们总共将产生 168.9 亿美元的服务收入,每年增长 17%。
该资料库基于30 年的生物製药和生命科学行业评估和基准,不断更新以包含全面的资讯和见解。
"Top300 Bio CDMO 设施指数" 对每个 "专用" CDMO 设施进行排名,并按区域提供生物製造区域/栅格的定量分析。
The only Global Contract Development and Manufacturing Facilities Database subscription that actively tracks over 400+ dedicated CDMO facilities providing development and manufacturing services for biopharmaceuticals.
Hundreds of facilities manufacturing clinical and commercial scale biologics, account for $16.89 billion in services sales in 2023, growing at 17% annually.
Based on 30 years of evaluating and benchmarking the biopharmaceutical and life sciences industry, this database is updated continually and includes comprehensive information and insights.
"Top300 Bio CDMO Facility Index" ranks each 'dedicated' CDMO facility and provides regional quantitative analysis of biomanufacturing regions and clusters.